CLINICAL_TRIALS
withdrawal
· 2017-01-24
Clinical Trial Update: Celecoxib (Celebrex) in the Management of Acute Renal Colic [Phase 4]
Summary
A Phase 4 trial evaluating Celecoxib for acute renal colic due to ureteral calculi has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Ureteral Calculi | Phase 4 | Status: WITHDRAWN